Quick Answer
Centessa Pharmaceuticals plc reported Net Income of -$197.53 million for fiscal year 2025.
Centessa Pharmaceuticals plc Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$197.53M | +16.2% |
| 2024 | -$235.76M | -56.0% |
| 2023 | -$151.09M | +30.1% |
| 2022 | -$216.21M | +43.3% |
| 2021 | -$381.07M | -45867.6% |
| 2021 | -$829.0K | +92.2% |
| 2020 | -$10.66M | -110.7% |
| 2019 | -$5.06M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$54.89M | -29.0% | -9.0% |
| June 30, 2025 | -$50.34M | -14.9% | -92.6% |
| March 31, 2025 | -$26.14M | +31.3% | +38.6% |
| September 30, 2024 | -$42.57M | -10.1% | +2.9% |
| June 30, 2024 | -$43.82M | -76.1% | -15.2% |
| March 31, 2024 | -$38.05M | +25.0% | +1.6% |
| September 30, 2023 | -$38.65M | +28.3% | -55.3% |
| June 30, 2023 | -$24.89M | +61.5% | +50.9% |
- Centessa Pharmaceuticals plc showed an increase of +16.2% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Centessa Pharmaceuticals plc’s net income has declined by 3803.0% (from -$5.06 million to -$197.53 million).
- The most recent figure is from Centessa Pharmaceuticals plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: